Amniotics AB (publ)

Amniotics AB (publ)verified

AMNI.ST

Price:

$0.0054

Market Cap:

$14.76M

Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; and CutiStem for the treatment of dermatological indications. The company offers contract development and contract manufacturing services for advanced therapy medicinal products to the pharmaceutical industries, universities, and hospitals. Amniotics AB (publ) was incorporated in 2015 and is based in Lund, Sweden.

Industry

Biotechnology

IPO Date

2021-07-06

Stock Exchange

STO

Ticker

AMNI.ST

The PE Ratio as of December 2025 (TTM) for Amniotics AB (publ) (AMNI.ST) is 0.01

According to Amniotics AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is 0.01. This represents a change of -103.31% compared to the average of -0.25 of the last 4 quarters.

Amniotics AB (publ) (AMNI.ST) Historical PE Ratio (quarterly & annually)

How has AMNI.ST PE Ratio performed in the past?

The mean historical PE Ratio of Amniotics AB (publ) over the last ten years is -37.27. The current 0.01 PE Ratio has changed -102.23% with respect to the historical average. Over the past ten years (40 quarters), AMNI.ST's PE Ratio was at its highest in in the September 2023 quarter at -0.03. The PE Ratio was at its lowest in in the March 2020 quarter at -8.48.

Quarterly (TTM)
Annual

Average

-37.27

Median

-17.94

Minimum

-111.99

Maximum

-0.82

Amniotics AB (publ) (AMNI.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Amniotics AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = -0.82

Minimum Annual Increase = -88.17%

Minimum Annual PE Ratio = -111.99

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.82-37.68%
2022-1.31-88.17%
2021-11.10-55.21%
2020-24.78-66.36%
2019-73.65-34.23%

Amniotics AB (publ) (AMNI.ST) Average PE Ratio

How has AMNI.ST PE Ratio performed in the past?

The current PE Ratio of Amniotics AB (publ) (AMNI.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.41

5-year avg

-22.33

10-year avg

-37.27

Amniotics AB (publ) (AMNI.ST) PE Ratio vs. Peers

How is AMNI.ST’s PE Ratio compared to its peers?

Amniotics AB (publ)’s PE Ratio is greater than Idogen AB (publ) (-0.16), greater than Pharmiva AB (publ) (-0.41), greater than Diagonal Bio AB (publ) (-2.16), greater than Ziccum AB (publ) (-0.29), greater than Cyxone AB (publ) (-0.08), greater than Redwood Pharma AB (-0.00), greater than Scandion Oncology A/S (-0.02), greater than Cline Scientific AB (publ) (-0.66), greater than Asarina Pharma AB (publ) (-0.05), greater than Kancera AB (publ) (-0.90),

Build a custom stock screener for Amniotics AB (publ) (AMNI.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amniotics AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amniotics AB (publ) (AMNI.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amniotics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Amniotics AB (publ)'s PE Ratio?

How is the PE Ratio calculated for Amniotics AB (publ) (AMNI.ST)?

What is the highest PE Ratio for Amniotics AB (publ) (AMNI.ST)?

What is the 3-year average PE Ratio for Amniotics AB (publ) (AMNI.ST)?

What is the 5-year average PE Ratio for Amniotics AB (publ) (AMNI.ST)?

How does the current PE Ratio for Amniotics AB (publ) (AMNI.ST) compare to its historical average?